Concepedia
Statistics
Publications
18
Citations
1.8K
H-Index
16
Active since
2012
Affiliations
University of Manchester(Current)
Nottingham Trent University
University College London
Manchester Academic Health Science Centre
King's College London
Zahraa S. Al-Ahmady is an author at University of Manchester specializing in pharmacy, drug delivery, and nanomedicine.
Publications per year
2012–2022
<i>In Vivo</i> Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles
Marilena Hadjidemetriou, Zahraa S. Al-Ahmady, Mariarosa Mazza et al. · ACS Nano · 2015 · 336 citations
Pharmacy, Biochemistry, Pharmaceutics +17
Lipid–Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia <i>in Vitro</i> and <i>in Vivo</i>
Zahraa S. Al-Ahmady, Wafa’ T. Al-Jamal, Jeroen Van den Bossche et al. · ACS Nano · 2012 · 219 citations
Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles
Marilena Hadjidemetriou, Zahraa S. Al-Ahmady, Kostas Kostarelos · Nanoscale · 2016 · 207 citations · Full text
Pharmacy, Biochemistry, Pharmacology +17
The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof‐of‐Concept Clinical Study
Marilena Hadjidemetriou, Sarah McAdam, Grace Garner et al. · Advanced Materials · 2018 · 173 citations
Pharmacy, Biochemistry, Oncology +17
Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent
Neus Lozano, Zahraa S. Al-Ahmady, Nicolas Bézière et al. · International Journal of Pharmaceutics · 2014 · 110 citations
Pharmacy, Pharmaceutics, Pharmacology +14
1–5 of 18